(1)
Strober, B.; Augustin, M.; Tada, Y.; Garg, A.; Jullien, D.; Gottlieb, A.; Gudjonsson, J.; Hu, N.; Hofmann, P.; Thoma, C.; Marzano, A. Effect of High-Dose Subcutaneous Spesolimab on Skin Manifestations: Results from the Pivotal Effisayil 2 Trial of Flare Prevention in Generalized Pustular Psoriasis. J of Skin 2024, 8, s371.